Kevin Robert Lind - 09 Feb 2022 Form 4 Insider Report for Longboard Pharmaceuticals, Inc. (LBPH)

Role
CEO, Director
Signature
/s/ Brandi L. Roberts, Attorney-In-Fact
Issuer symbol
LBPH
Transactions as of
09 Feb 2022
Net transactions value
$0
Form type
4
Filing time
11 Feb 2022, 15:48:10 UTC
Next filing
10 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LBPH Stock Option (Right to Buy) Award $0 +195,000 $0.000000 195,000 09 Feb 2022 Voting common stock 195,000 $4.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the stock option vest and become exercisable in 48 equal monthly installments commencing March 9, 2022.